"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 12 | 12 |
| 1996 | 0 | 10 | 10 |
| 1997 | 0 | 16 | 16 |
| 1998 | 0 | 15 | 15 |
| 1999 | 0 | 15 | 15 |
| 2000 | 0 | 7 | 7 |
| 2001 | 0 | 19 | 19 |
| 2002 | 0 | 22 | 22 |
| 2003 | 0 | 19 | 19 |
| 2004 | 0 | 14 | 14 |
| 2005 | 0 | 16 | 16 |
| 2006 | 0 | 10 | 10 |
| 2007 | 0 | 19 | 19 |
| 2008 | 0 | 13 | 13 |
| 2009 | 0 | 18 | 18 |
| 2010 | 0 | 14 | 14 |
| 2011 | 0 | 17 | 17 |
| 2012 | 0 | 12 | 12 |
| 2013 | 0 | 19 | 19 |
| 2014 | 0 | 15 | 15 |
| 2015 | 0 | 15 | 15 |
| 2016 | 0 | 21 | 21 |
| 2017 | 0 | 18 | 18 |
| 2018 | 0 | 22 | 22 |
| 2019 | 0 | 16 | 16 |
| 2020 | 0 | 19 | 19 |
| 2021 | 0 | 13 | 13 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 6 | 6 |
| 2024 | 0 | 7 | 7 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Effect of postpartum oral furosemide use on postpartum readmissions and blood pressure trends. Pregnancy Hypertens. 2025 Mar; 39:101199.
-
Advancing the Harmonization of Biopredictive Methodologies through the Product Quality Research Institute (PQRI) Consortium: Biopredictive Dissolution of Dipyridamole Tablets. Mol Pharm. 2024 Oct 07; 21(10):5315-5325.
-
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. N Engl J Med. 2024 08 22; 391(8):710-721.
-
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers. J Int AIDS Soc. 2024 Jul; 27 Suppl 3:e26319.
-
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial. JAMA. 2024 05 28; 331(20):1714-1721.
-
Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024 Jul 01; 144(1):126-134.
-
Safety and feasibility of intravenous sotalol loading for the prevention of ventricular arrhythmias. J Interv Card Electrophysiol. 2024 Oct; 67(7):1647-1655.
-
Therapeutic Drug Monitoring of Oral Oncology Drugs: Another Example of Maslow's Hammer. Clin Pharmacol Ther. 2024 Sep; 116(3):508-510.
-
A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice. Nat Biomed Eng. 2024 May; 8(5):611-627.
-
Fabrication of solid lipid nanoparticles-based patches of paroxetine and their ex-vivo permeation behaviour. Artif Cells Nanomed Biotechnol. 2023 Dec; 51(1):108-119.